P47 phox contributes to albuminuria and kidney fibrosis in mice

Kidney International

Volumn 87, Issue 5, 2015, Pages 948-962

  Wang, Hongtao ^a   Chen, Xiwu ^a   Su, Yan ^a   Paueksakon, Paisit ^a   Hu, Wen ^a   Zhang, Ming Zhi ^a   Harris, Raymond C ^a,b   Blackwell, Timothy S ^a   Zent, Roy ^a,b   Pozzi, Ambra ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

adriamycin; glomerulosclerosis; integrins; NOX; partial renal ablation; reactive oxygen species

Indexed keywords

ALPHA1 INTEGRIN; COLLAGEN TYPE 4; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; OXIDOREDUCTASE; P47PHOX PROTEIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; UNCLASSIFIED DRUG; EGFR PROTEIN, MOUSE; NEUTROPHIL CYTOSOLIC FACTOR 1; RAC PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL LOSS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME INHIBITION; GLOMERULOPATHY; GLOMERULOSCLEROSIS; IN VITRO STUDY; KIDNEY FIBROSIS; KNOCKOUT MOUSE; MACROPHAGE; MALE; MESANGIUM CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PODOCYTE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN TARGETING; RENAL ABLATION; SIGNAL TRANSDUCTION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; ENZYMOLOGY; GENETICS; KIDNEY; METABOLISM; NEPHROSCLEROSIS;

ALBUMINURIA; ANIMALS; COLLAGEN TYPE IV; DOXORUBICIN; INTEGRIN ALPHA1; KIDNEY; MALE; MICE, INBRED BALB C; MICE, INBRED C57BL; NADPH OXIDASE; NEPHROSCLEROSIS; OXIDATIVE STRESS; RAC GTP-BINDING PROTEINS; REACTIVE OXYGEN SPECIES; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84929129558     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.386     Document Type: Article

References (69)

1. Schell C, Huber TB. New players in the pathogenesis of focal segmental glomerulosclerosis. Nephrol Dial Transplant 2012; 27: 3406-3412.
2. Borza CM, Pozzi A. The role of cell-extracellular matrix interactions in glomerular injury. Exp Cell Res 2012; 318: 1001-1010.
3. Modlinger PS, Wilcox CS, Aslam S. Nitric oxide, oxidative stress, and progression of chronic renal failure. Semin Nephrol 2004; 24: 354-365.
4. Pozzi A, Zent R. Integrins in kidney disease. J Am Soc Nephrol 2013; 24: 1034-1039.
5. Coaccioli S, Crapa G, Fantera M et al. Oxidant/antioxidant status in patients with chronic HIV infection. Clin Ter 2010; 161: 55-58.
6. Satoh M, Fujimoto S, Haruna Y et al. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am J Physiol Renal Physiol 2005; 288: F1144-F1152.
7. Zuo L, Otenbaker NP, Rose BA et al. Molecular mechanisms of reactive oxygen species-related pulmonary inflammation and asthma. Mol Immunol 2013; 56: 57-63.
8. Sardina JL, Lopez-Ruano G, Sanchez-Sanchez B et al. Reactive oxygen species: are they important for haematopoiesis? Crit Rev Oncol Hematol 2012; 81: 257-274.
9. Touyz RM, Briones AM. Reactive oxygen species and vascular biology: implications in human hypertension. Hypertens Res 2011; 34: 5-14.
10. Massaad CA. Neuronal and vascular oxidative stress in Alzheimer's disease. Curr Neuropharmacol 2011; 9: 662-673.
11. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007; 87: 245-313.
12. Paravicini TM, Touyz RM. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 2008; 31(Suppl 2): S170-S180.
13. You YH, Okada S, Ly S et al. Role of Nox2 in diabetic kidney disease. Am J Physiol Renal Physiol 2013; 304: F840-F848.
14. Bokoch GM, Zhao T. Regulation of the phagocyte NADPH oxidase by Rac GTPase. Antioxid Redox Signal 2006; 8: 1533-1548.
15. Katsuyama M, Matsuno K, Yabe-Nishimura C. Physiological roles of NOX/ NADPH oxidase, the superoxide-generating enzyme. J Clin Biochem Nutr 2012; 50: 9-22.
16. Geiszt M. NADPH oxidases: new kids on the block. Cardiovasc Res 2006; 71: 289-299.
17. Eid AA, Ford BM, Block K et al. AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes. J Biol Chem 2010; 285: 37503-37512.
18. Sedeek M, Callera G, Montezano A et al. Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy. Am J Physiol Renal Physiol 2010; 299: F1348-F1358.
19. Eid AA, Ford BM, Bhandary B et al. mTOR regulates Nox4-mediated podocyte depletion in diabetic renal injury. Diabetes 2013; 62: 2935-2947.
20. Babelova A, Avaniadi D, Jung O et al. Role of Nox4 in murine models of kidney disease. Free Radic Biol Med 2012; 53: 842-853.
21. Nlandu Khodo S, Dizin E, Sossauer G et al. NADPH-oxidase 4 protects against kidney fibrosis during chronic renal injury. J Am Soc Nephrol 2012; 23: 1967-1976.
22. Kitada M, Koya D, Sugimoto T et al. Translocation of glomerular p47phox and p67phox by protein kinase C-beta activation is required for oxidative stress in diabetic nephropathy. Diabetes 2003; 52: 2603-2614.
23. Salguero G, Akin E, Templin C et al. Renovascular hypertension by twokidney one-clip enhances endothelial progenitor cell mobilization in a p47phox-dependent manner. J Hypertens 2008; 26: 257-268.
24. Liu GC, Fang F, Zhou J et al. Deletion of p47phox attenuates the progression of diabetic nephropathy and reduces the severity of diabetes in the Akita mouse. Diabetologia 2012; 55: 2522-2532.
25. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002; 110: 673-687.
26. Mathew S, Chen X, Pozzi A et al. Integrins in renal development. Pediatr Nephrol 2012; 27: 891-900.
27. Pozzi A, Zent R. Integrins: sensors of extracellular matrix and modulators of cell function. Nephron Exp Nephrol 2003; 94: e77-e84.
28. Chen X, Abair TD, Ibanez MR et al. Integrin alpha1beta1 controls reactive oxygen species synthesis by negatively regulating epidermal growth factor receptor-mediated Rac activation. Mol Cell Biol 2007; 27: 3313-3326.
29. Chen X, Moeckel G, Morrow JD et al. Lack of integrin alpha1beta1 leads to severe glomerulosclerosis after glomerular injury. Am J Pathol 2004; 165: 617-630.
30. Zent R, Yan X, Su Y et al. Glomerular injury is exacerbated in diabetic integrin alpha1-null mice. Kidney Int 2006; 70: 460-470.
31. Borza CM, Su Y, Chen X et al. Inhibition of integrin alpha2beta1 ameliorates glomerular injury. J Am Soc Nephrol 2012; 23: 1027-1038.
32. Honore S, Kovacic H, Pichard V et al. Alpha2beta1-integrin signaling by itself controls G1/S transition in a human adenocarcinoma cell line (Caco-2): implication of NADPH oxidase-dependent production of ROS. Exp Cell Res 2003; 285: 59-71.
33. Gao XP, Standiford TJ, Rahman A et al. Role of NADPH oxidase in the mechanism of lung neutrophil sequestration and microvessel injury induced by Gram-negative sepsis: studies in p47phox-/-and gp91phox-/-mice. J Immunol 2002; 168: 3974-3982.
34. Han W, Li H, Cai J et al. NADPH oxidase limits lipopolysaccharide-induced lung inflammation and injury in mice through reduction-oxidation regulation of NF-kappaB activity. J Immunol 2013; 190: 4786-4794.
35. Eid AA, Gorin Y, Fagg BM et al. Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. Diabetes 2009; 58: 1201-1211.
36. Jha JC, Gray SP, Barit D et al. Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy. J Am Soc Nephrol 2014; 25: 1237-1254.
37. Chen A, Sheu LF, Ho YS et al. Experimental focal segmental glomerulosclerosis in mice. Nephron 1998; 78: 440-452.
38. Wang Y, Wang YP, Tay YC et al. Progressive adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events. Kidney Int 2000; 58: 1797-1804.
39. Gorin Y, Block K. Nox as a target for diabetic complications. Clin Sci (Lond) 2013; 125: 361-382.
40. Bollee G, Flamant M, Schordan S et al. Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis. Nat Med 2011; 17: 1242-1250.
41. Tang J, Liu N, Tolbert E et al. Sustained activation of EGFR triggers renal fibrogenesis after acute kidney injury. Am J Pathol 2013; 183: 160-172.
42. Wolf-Goldberg T, Barbul A, Ben-Dov N et al. Low electric fields induce ligand-independent activation of EGF receptor and ERK via electrochemical elevation of H(+) and ROS concentrations. Biochim Biophys Acta 2013; 1833: 1396-1408.
43. Cosgrove D, Meehan DT, Delimont D et al. Integrin alpha1beta1 regulates matrix metalloproteinases via P38 mitogen-activated protein kinase in mesangial cells: implications for Alport syndrome. Am J Pathol 2008; 172: 761-773.
44. Reich H, Tritchler D, Herzenberg AM et al. Albumin activates ERK via EGF receptor in human renal epithelial cells. J Am Soc Nephrol 2005; 16: 1266-1278.
45. Rybak AP, Ingram AJ, Tang D. Propagation of human prostate cancer stem-like cells occurs through EGFR-mediated ERK activation. PLoS One 2013; 8: e61716.
46. Dong QZ, Wang Y, Tang ZP et al. Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9. Am J Pathol 2013; 182: 954-964.
47. Yang H, Guo H, Fan K et al. Clearance of Propionibacterium acnes by kupffer cells is regulated by osteopontin through modulating the expression of p47phox. Mol Immunol 2011; 48: 2019-2026.
48. Makni-Maalej K, Chiandotto M, Hurtado-Nedelec M et al. Zymosan induces NADPH oxidase activation in human neutrophils by inducing the phosphorylation of p47phox and the activation of Rac2: involvement of protein tyrosine kinases, PI3Kinase, PKC, ERK1/2 and p38MAPkinase. Biochem Pharmacol 2013; 85: 92-100.
49. Ford BM, Eid AA, Gooz M et al. ADAM17 mediates Nox4 expression and NADPH oxidase activity in the kidney cortex of OVE26 mice. Am J Physiol Renal Physiol 2013; 305: F323-F332.
50. Pendyala S, Natarajan V. Redox regulation of Nox proteins. Resp Physiol Neurobiol 2010; 174: 265-271.
51. Zhang M, Brewer AC, Schroder K et al. NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc Natl Acad Sci USA 2010; 107: 18121-18126.
52. Bataller R, Schwabe RF, Choi YH et al. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest 2003; 112: 1383-1394.
53. Bodiga S, Zhong JC, Wang W et al. Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit. Cardiovasc Res 2011; 91: 151-161.
54. Patel VB, Wang Z, Fan D et al. Loss of p47phox Subunit Enhances Susceptibility to Biomechanical Stress and Heart Failure Because of Dysregulation of Cortactin and Actin Filaments. Circ Res 2013; 112: 1542-1556.
55. Zoja C, Abbate M, Remuzzi G. Progression of renal injury toward interstitial inflammation and glomerular sclerosis isdependent on abnormal protein filtration. Nephrol Dial Transplant 2014 (e-pub ahead of print).
56. van den Berg JG, van den Bergh Weerman MA, Assmann KJ et al. Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies. Kidney Int 2004; 66: 1901-1906.
57. Orikasa M, Matsui K, Oite T et al. Massive proteinuria induced in rats by a single intravenous injection of a monoclonal antibody. J Immunol 1988; 141: 807-814.
58. Liu G, Kaw B, Kurfis J et al. Neph1 and nephrin interaction in the slit diaphragm is an important determinant of glomerular permeability. J Clin Invest 2003; 112: 209-221.
59. Sedeek M, Gutsol A, Montezano AC et al. Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes. Clin Sci (Lond) 2013; 124: 191-202.
60. Lassegue B, Clempus RE. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 2003; 285: R277-R297.
61. Tung WH, Hsieh HL, Lee IT et al. Enterovirus 71 induces integrin beta1/ EGFR-Rac1-dependent oxidative stress in SK-N-SH cells: role of HO-1/CO in viral replication. J Cell Physiol 2011; 226: 3316-3329.
62. Werner E, Werb Z. Integrins engage mitochondrial function for signal transduction by a mechanism dependent on Rho GTPases. J Cell Biol 2002; 158: 357-368.
63. Taddei ML, Parri M, Mello T et al. Integrin-mediated cell adhesion and spreading engage different sources of reactive oxygen species. Antioxid Redox Signal 2007; 9: 469-481.
64. Lin LJ, Grimme JM, Sun J et al. The antagonistic roles of PDGF and integrin alphavbeta3 in regulating ROS production at focal adhesions. Biomaterials 2013; 34: 3807-3815.
65. Volpe JP, Cleaver JE. Xeroderma pigmentosum variant cells are resistant to immortalization. Mutat Res 1995; 337: 111-117.
66. Zhang MZ, Wang S, Yang S et al. Role of blood pressure and the reninangiotensin system in development of diabetic nephropathy (DN) in eNOS-/-db/db mice. Am J Physiol Renal Physiol 2012; 302: F433-F438.
67. Yao B, Harris RC, Zhang MZ. Intrarenal dopamine attenuates deoxycorticosterone acetate/high salt-induced blood pressure elevation in part through activation of a medullary cyclooxygenase 2 pathway. Hypertension 2009; 54: 1077-1083.
68. Takagi N, Tanizawa T, Kon V et al. Mineralocorticoid Receptor Blocker Protects against Podocyte-Dependent Glomerulosclerosis. Nephron Extra 2012; 2: 17-26.
69. Chen X, Whiting C, Borza C et al. Integrin alpha1beta1 regulates epidermal growth factor receptor activation by controlling peroxisome proliferator-activated receptor gamma-dependent caveolin-1 expression. Mol Cell Biol 2010; 30: 3048-3058.